Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Hartmaier RJ"'
Autor:
Gray JE; Department of Thoracic Oncology, Moffitt Cancer Center, Tampa, Florida., Ahn MJ; Section of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Oxnard GR; Dana-Farber Cancer Institute, Boston, Massachusetts., Shepherd FA; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Imamura F; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Cheng Y; Department of Oncology, Cancer Hospital of Jilin Province, Changchun, China., Okamoto I; Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University Hospital, Fukuoka, Japan., Cho BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Lin MC; Division of Pulmonary and Critical Care Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University, Kaohsiung, Taiwan., Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital & Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China., Majem M; Department of Medical Oncology, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain., Gautschi O; University of Berne and Cantonal Hospital of Lucerne, Lucerne, Switzerland., Boyer M; Department of Medical Oncology, Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia., Bulusu KC; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Markovets A; Translational Medicine, Oncology R&D, AstraZeneca, Boston, Massachusetts., Barrett JC; Translational Medicine, Oncology R&D, AstraZeneca, Boston, Massachusetts., Hodge R; Late Oncology Statistics, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., McKeown A; Clinical Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Hartmaier RJ; Translational Medicine, Oncology R&D, AstraZeneca, Boston, Massachusetts., Chmielecki J; Translational Medicine, Oncology R&D, AstraZeneca, Boston, Massachusetts., Papadimitrakopoulou VA; The University of Texas MD Anderson Cancer Center, Houston, Texas., Ramalingam SS; Emory University School of Medicine, Winship Cancer Institute, Atlanta, Georgia.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Sep 01; Vol. 29 (17), pp. 3340-3351.
Autor:
Chmielecki J; Translational Medicine, Oncology R&D, AstraZeneca, Boston, MA, USA., Gray JE; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA. Jhanelle.Gray@moffitt.org., Cheng Y; Jilin Provincial Cancer Hospital, Changchun, China., Ohe Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Imamura F; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Cho BC; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Lin MC; Division of Pulmonary and Critical Care Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University, Kaohsiung, Taiwan., Majem M; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Shah R; Kent Oncology Centre, Maidstone Hospital, Maidstone and Tunbridge Wells NHS Trust, Maidstone, UK., Rukazenkov Y; Oncology R&D, AstraZeneca, Cambridge, UK., Todd A; Oncology Biometrics, Oncology R&D, AstraZeneca, Cambridge, UK., Markovets A; Translational Medicine, Oncology R&D, AstraZeneca, Boston, MA, USA., Barrett JC; Translational Medicine, Oncology R&D, AstraZeneca, Boston, MA, USA., Hartmaier RJ; Translational Medicine, Oncology R&D, AstraZeneca, Boston, MA, USA., Ramalingam SS; Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Publikováno v:
Nature communications [Nat Commun] 2023 Jun 01; Vol. 14 (1), pp. 3179. Date of Electronic Publication: 2023 Jun 01.
Autor:
Chmielecki J; Translational Medicine, Oncology R&D, AstraZeneca, Boston, MA, USA., Gray JE; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA. Jhanelle.Gray@moffitt.org., Cheng Y; Jilin Provincial Cancer Hospital, Changchun, China., Ohe Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Imamura F; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Cho BC; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Lin MC; Division of Pulmonary and Critical Care Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University, Kaohsiung, Taiwan., Majem M; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Shah R; Kent Oncology Centre, Maidstone Hospital, Maidstone and Tunbridge Wells NHS Trust, Maidstone, UK., Rukazenkov Y; Oncology R&D, AstraZeneca, Cambridge, UK., Todd A; Oncology Biometrics, Oncology R&D, AstraZeneca, Cambridge, UK., Markovets A; Translational Medicine, Oncology R&D, AstraZeneca, Boston, MA, USA., Barrett JC; Translational Medicine, Oncology R&D, AstraZeneca, Boston, MA, USA., Hartmaier RJ; Translational Medicine, Oncology R&D, AstraZeneca, Boston, MA, USA., Ramalingam SS; Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Publikováno v:
Nature communications [Nat Commun] 2023 Feb 27; Vol. 14 (1), pp. 1070. Date of Electronic Publication: 2023 Feb 27.
Autor:
Chmielecki J; Translational Medicine, Oncology R&D, AstraZeneca, Boston, MA, USA., Mok T; State Key Laboratory of Translational Oncology, Department of Clinical Oncology, Chinese University of Hong Kong, Hong Kong, China., Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China., Han JY; Center for Lung Cancer, National Cancer Center, Goyang, Republic of Korea., Ahn MJ; Section of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Ramalingam SS; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA., John T; Medical Oncology, Olivia Newton-John Cancer Research Institute, Austin Health, Melbourne, VIC, Australia., Okamoto I; Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Yang JC; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan., Shepherd FA; Departments of Medical Oncology and Hematology, Princess Margaret Cancer Centre, and the University of Toronto, Toronto, ON, Canada., Bulusu KC; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, UK., Laus G; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, UK.; Clinical Development, Merus, Utrecht, The Netherlands., Collins B; Biometrics and Information Sciences, AstraZeneca, Cambridge, UK.; Simbiotic Consulting Ltd, Glasgow, UK., Barrett JC; Translational Medicine, Oncology R&D, AstraZeneca, Boston, MA, USA., Hartmaier RJ; Translational Medicine, Oncology R&D, AstraZeneca, Boston, MA, USA., Papadimitrakopoulou V; Department of Thoracic/Head and Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. vpapadimitrakopoulou@gmail.com.; Clinical Development, Pfizer Inc, Houston, TX, USA. vpapadimitrakopoulou@gmail.com.
Publikováno v:
Nature communications [Nat Commun] 2023 Feb 27; Vol. 14 (1), pp. 1071. Date of Electronic Publication: 2023 Feb 27.
Autor:
Hartmaier RJ; Translational Medicine, Research and Early Development, Oncology R&D, AstraZeneca, Boston, Massachusetts., Markovets AA; Translational Medicine, Research and Early Development, Oncology R&D, AstraZeneca, Boston, Massachusetts., Ahn MJ; Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, Republic of Korea., Sequist LV; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts., Han JY; Center for Lung Cancer, National Cancer Center, Goyang, Republic of Korea., Cho BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Yu HA; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Kim SW; Department of Oncology, University of Uslan College of Medicine, Asan Medical Center, Seoul, Republic of Korea., Yang JC; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei City, Taiwan., Lee JS; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul, Republic of Korea., Su WC; Department of Internal Medicine, National Cheng Kung University Hospital, Tainan City, Taiwan., Kowalski DM; Department of Lung Cancer and Thoracic Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Orlov S; BioEq, LLC, Saint Petersburg, Russian Federation., Ren S; Clinical Pharmacology and Quantitative Pharmacology, AstraZeneca, Gaithersburg, Maryland., Frewer P; Oncology Biometrics, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Ou X; Oncology Biometrics, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Cross DAE; Oncology Late Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Kurian N; Precision Medicine and Biosamples, Oncology R&D, AstraZeneca, Boston, Massachusetts., Cantarini M; Oncology Late Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Jänne PA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
Cancer discovery [Cancer Discov] 2023 Jan 09; Vol. 13 (1), pp. 98-113.
Autor:
Yang JC; National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan., Ohe Y; National Cancer Center Hospital, Tokyo, Japan., Chiu CH; Taipei Veterans General Hospital, Taipei, Taiwan., Ou X; Early Clinical Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Cantarini M; Late Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Jänne PA; Lowe Center for Thoracic Oncology and the Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Hartmaier RJ; Translational Medicine, Oncology R&D, AstraZeneca, Waltham, Massachusetts., Ahn MJ; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Jun 23, pp. OF1-OF10. Date of Electronic Publication: 2022 Jun 23.
Autor:
Watters RJ; Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA.; Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.; Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh, PA 15213, USA., Verdelis K; Center for Craniofacial Regeneration, School of Dental Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA., Lucas PC; Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh, PA 15213, USA.; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA., Jiang S; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., Chen Y; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., Lu F; Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA.; School of Medicine, Tsinghua University, Beijing, China., Martin BM; Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA., Lukashova L; Center for Craniofacial Regeneration, School of Dental Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA., Pecar G; Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.; Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh, PA 15213, USA., Morales-Restrepo A; Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA., Hankins M; Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA., Zhu L; Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA 15213, USA., Mittwede P; Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA., Hartmaier RJ; Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh, PA 15213, USA., Alexander PG; Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA., Tseng GC; Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA 15213, USA., Weiss KR; Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA., Galson DL; Department of Medicine, Division of Hematology/Oncology, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA 15232, USA., Lee AV; Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA.; Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.; Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh, PA 15213, USA., Lee B; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., Oesterreich S; Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA.; Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.; Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh, PA 15213, USA.
Publikováno v:
Endocrinology [Endocrinology] 2021 Aug 01; Vol. 162 (8).
Autor:
Rinaldi J; Department of Bioinformatics & Computational Biology, Genentech Inc., South San Francisco, CA, United States of America., Sokol ES; Foundation Medicine, Cambridge, MA, United States of America., Hartmaier RJ; Foundation Medicine, Cambridge, MA, United States of America., Trabucco SE; Foundation Medicine, Cambridge, MA, United States of America., Frampton GM; Foundation Medicine, Cambridge, MA, United States of America., Goldberg ME; Foundation Medicine, Cambridge, MA, United States of America., Albacker LA; Foundation Medicine, Cambridge, MA, United States of America., Daemen A; Department of Bioinformatics & Computational Biology, Genentech Inc., South San Francisco, CA, United States of America., Manning G; Department of Bioinformatics & Computational Biology, Genentech Inc., South San Francisco, CA, United States of America.
Publikováno v:
PloS one [PLoS One] 2020 May 06; Vol. 15 (5), pp. e0231999. Date of Electronic Publication: 2020 May 06 (Print Publication: 2020).
Autor:
Trabucco SE; Department of Research and Development, Foundation Medicine, Inc., Cambridge, Massachusetts. Electronic address: strabucco@foundationmedicine.com., Gowen K; Department of Research and Development, Foundation Medicine, Inc., Cambridge, Massachusetts., Maund SL; Department of Oncology Biomarker Development, Genentech, Inc., San Francisco, California., Sanford E; Department of Research and Development, Foundation Medicine, Inc., Cambridge, Massachusetts., Fabrizio DA; Department of Research and Development, Foundation Medicine, Inc., Cambridge, Massachusetts., Hall MJ; Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Yakirevich E; Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School of Brown University, Providence, Rhode Island., Gregg JP; Department of Research and Development, Foundation Medicine, Inc., Cambridge, Massachusetts; Department of Pathology and Laboratory Medicine, UC Davis Health, Sacramento, California., Stephens PJ; Department of Research and Development, Foundation Medicine, Inc., Cambridge, Massachusetts., Frampton GM; Department of Research and Development, Foundation Medicine, Inc., Cambridge, Massachusetts., Hegde PS; Department of Oncology Biomarker Development, Genentech, Inc., San Francisco, California., Miller VA; Department of Research and Development, Foundation Medicine, Inc., Cambridge, Massachusetts., Ross JS; Department of Research and Development, Foundation Medicine, Inc., Cambridge, Massachusetts., Hartmaier RJ; Department of Research and Development, Foundation Medicine, Inc., Cambridge, Massachusetts., Huang SA; Department of Oncology Biomarker Development, Genentech, Inc., San Francisco, California., Sun JX; Department of Research and Development, Foundation Medicine, Inc., Cambridge, Massachusetts.
Publikováno v:
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2019 Nov; Vol. 21 (6), pp. 1053-1066. Date of Electronic Publication: 2019 Aug 22.
Autor:
Vartanian S; Department of Discovery Oncology., Lee J; Department of Discovery Oncology., Klijn C; Department of Bioinformatics and Computational Biology., Gnad F; Department of Bioinformatics and Computational Biology., Bagniewska M; Department of Discovery Oncology., Schaefer G; Department of Translation Oncology., Zhang D; Department of Drug Metabolism and Pharmacokinetics., Tan J; Department of Discovery Oncology., Watson SA; Department of Discovery Oncology., Liu L; Department of Drug Metabolism and Pharmacokinetics., Chen H; Department of Molecular Biology, Genentech Inc., South San Francisco, California., Liang Y; Department of Molecular Biology, Genentech Inc., South San Francisco, California., Watanabe C; Department of Bioinformatics and Computational Biology., Cuellar T; Department of Molecular Biology, Genentech Inc., South San Francisco, California., Kan D; Department of Translation Oncology., Hartmaier RJ; Foundation Medicine Inc., Cambridge, Massachusetts., Lau T; Department of Discovery Oncology., Costa MR; Department of Discovery Oncology., Martin SE; Department of Discovery Oncology., Merchant M; Department of Translation Oncology., Haley B; Department of Molecular Biology, Genentech Inc., South San Francisco, California., Stokoe D; Department of Discovery Oncology. dstokoe@pacbell.net.
Publikováno v:
Cancer research [Cancer Res] 2019 Oct 01; Vol. 79 (19), pp. 4828-4839. Date of Electronic Publication: 2019 Aug 15.